Evidence Health
← Search another medicinePrintable summary →

Meclizine Hcl 12.5 Mg

Also sold as MECLIZINE

From 1 official FDA drug label · RxNorm 995624

This comes from U.S. FDA labels. Brand names, strengths and advice can differ in your country; check with a local health professional. Set your country.

What it is used for

These are the uses the FDA has approved for this label. Using it for anything else is “off-label”: ask your prescriber why.

Uses prevents and treats nausea, vomiting or dizziness associated with motion sickness

How to take it

Directions dosage should be taken 1 hour before travel starts adults and children 12 years and over take 2 or 4 caplets once daily or as directed by a doctor

Serious warnings and precautions

Warnings Do not use in children under 12 years of age unless directed by a doctor. Do not take unless directed by a doctor if you have glaucoma a breathing problem such as emphysema or chronic bronchitis trouble urinating due to an enlarged prostate gland Do not take if you are taking sedatives or tranquilizers, without first consulting your doctor. When using this product do not exceed recommended dosage drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic drinks be careful when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

When using this product

When using this product do not exceed recommended dosage drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic drinks be careful when driving a motor vehicle or operating machinery

If you are pregnant or breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Forms and strengths available

25 MG · Disintegrating Oral Tablet50 MG · Chewable Tablet12.5 MG · Oral Tablet25 MG · Chewable Tablet25 MG · Oral Tablet30 MG · Oral Tablet50 MG · Oral Tablet

From RxNorm. Which forms and strengths are actually stocked varies by pharmacy and country.

Reactions people have reported

diarrhoea 3haemoglobin decreased 3dizziness 2abdominal pain 2bronchitis 2anaemia 1urinary tract infection 1endometriosis 1gastroenteritis 1anxiety 1

These are counts from 11 voluntary reports to the FDA. They show what has been reported — they are not how common a side effect is, and they do not prove the medicine caused it.

Recalls

Class II · Apr 1, 2026
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Reason: Failed tablet specifications.
Class II · Jun 15, 2022
Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15
Reason: cGMP deviations: Temperature abuse
Class I · Apr 6, 2022
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Reason: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Class III · Nov 20, 2019
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
Reason: Subpotent Drug
Class III · Nov 20, 2019
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,
Reason: Subpotent Drug
Class III · Nov 22, 2017
Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06
Reason: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

Research & studies

Recent higher-quality studies about Meclizine Hcl 12.5 Mg, from PubMed. We link to the source — titles only. This is not medical advice.

Similar medicines

Meclizine Hcl 12.5 Mg belongs to the Piperazine derivatives class. Other medicines in it:

Questions to ask your doctor or pharmacist

Why you can trust this

Everything above comes from official FDA drug labels (openFDA), not written by us. Here are the exact labels used.

This information explains the official label. It cannot tell you whether this medicine is right or safe for you personally — only a qualified health professional who knows your history can do that. Do not start, stop, or change a medicine based on this page alone.